These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 10709153)
21. Buspirone pharmacokinetics in patients with cirrhosis. Dalhoff K; Poulsen HE; Garred P; Placchi M; Gammans RE; Mayol RF; Pfeffer M Br J Clin Pharmacol; 1987 Oct; 24(4):547-50. PubMed ID: 3689635 [TBL] [Abstract][Full Text] [Related]
22. In vivo and in vitro diclofenac 5-hydroxylation mediated primarily by cytochrome P450 3A enzymes in common marmoset livers genotyped for P450 2C19 variants. Nakanishi K; Uehara S; Kusama T; Inoue T; Shimura K; Kamiya Y; Murayama N; Shimizu M; Uno Y; Sasaki E; Yamazaki H Biochem Pharmacol; 2018 Jun; 152():272-278. PubMed ID: 29626440 [TBL] [Abstract][Full Text] [Related]
23. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers. Lissy M; Stiff DD; Kowalski MM; Moore KA Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of diclofenac after oral administration of its potassium salt in sachet and tablet formulations. Marzo A; Dal Bo L; Verga F; Ceppi Monti N; Abbondati G; Tettamanti RA; Crivelli F; Uhr MR; Ismaili S Arzneimittelforschung; 2000 Jan; 50(1):43-7. PubMed ID: 10683715 [TBL] [Abstract][Full Text] [Related]
25. Diclofenac pharmacokinetic meta-analysis and dose recommendations for surgical pain in children aged 1-12 years. Standing JF; Tibboel D; Korpela R; Olkkola KT Paediatr Anaesth; 2011 Mar; 21(3):316-24. PubMed ID: 21276131 [TBL] [Abstract][Full Text] [Related]
26. A 3-way crossover study to evaluate the pharmacokinetic interaction between nateglinide and diclofenac in healthy volunteers. Anderson DM; Shelley S; Crick N; Buraglio M Int J Clin Pharmacol Ther; 2002 Oct; 40(10):457-64. PubMed ID: 12395978 [TBL] [Abstract][Full Text] [Related]
27. Comparative in vitro dissolution and in vivo bioequivalence of two diclofenac enteric coated formulations. Basmenji S; Valizadeh H; Zakeri-Milani P Arzneimittelforschung; 2011; 61(10):566-70. PubMed ID: 22164964 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic disposition of isoxicam in hepatic cirrhosis. Esquivel M; Ogilvie RI; East DS; Shaw DH; Heathcote J Clin Invest Med; 1987 Sep; 10(5):363-7. PubMed ID: 3677504 [TBL] [Abstract][Full Text] [Related]
29. Is diclofenac a valuable CYP2C9 probe in humans? Morin S; Loriot MA; Poirier JM; Tenneze L; Beaune PH; Funck-Brentano C; Jaillon P; Becquemont L Eur J Clin Pharmacol; 2001; 56(11):793-7. PubMed ID: 11294368 [TBL] [Abstract][Full Text] [Related]
30. Bioequivalence study of low-dose diclofenac potassium tablet formulations. Hinz B; Hug AM; Fotopoulos G; Gold MS Int J Clin Pharmacol Ther; 2009 Oct; 47(10):643-8. PubMed ID: 19825328 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study. Zhao RK; Cheng G; Tang J; Song J; Peng WX Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of diclofenac sodium in normal man. Hasan SM; Ahmed T; Talib N; Hasan F Pak J Pharm Sci; 2005 Jan; 18(1):18-24. PubMed ID: 16431378 [TBL] [Abstract][Full Text] [Related]
33. A pharmacokinetic analysis of diclofenac potassium soft-gelatin capsule in patients after bunionectomy. Kowalski M; Stoker DG; Bon C; Moore KA; Boesing SE Am J Ther; 2010; 17(5):460-8. PubMed ID: 19531931 [TBL] [Abstract][Full Text] [Related]
34. Effect of voriconazole on the pharmacokinetics of diclofenac. Hynninen VV; Olkkola KT; Leino K; Lundgren S; Neuvonen PJ; Rane A; Valtonen M; Laine K Fundam Clin Pharmacol; 2007 Dec; 21(6):651-6. PubMed ID: 18034666 [TBL] [Abstract][Full Text] [Related]
35. Short-term sucralfate administration alters potassium diclofenac absorption in healthy male volunteers. Pedrazzoli Júnior J; Pierossi Mde A; Muscará MN; Dias HB; da Silva CM; Mendes FD; de Nucci G Br J Clin Pharmacol; 1997 Jan; 43(1):104-8. PubMed ID: 9056060 [TBL] [Abstract][Full Text] [Related]
36. [Anti-rheumatic therapy in patients with liver diseases. Plasma levels of diclofenac and elimination of diclofenac and metabolites in urine of patients with liver disease]. Zimmerer J; Tittor W; Degen P Fortschr Med; 1982 Sep; 100(36):1683-8. PubMed ID: 7141370 [TBL] [Abstract][Full Text] [Related]
37. No effect of short term ranitidine intake on diclofenac pharmacokinetics. Leucuţa A; Vlase L; Farcau D; Nanulescu M Rom J Gastroenterol; 2004 Dec; 13(4):306-8. PubMed ID: 15624028 [TBL] [Abstract][Full Text] [Related]
38. Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study. Ganne-Carrié N; Christidis C; Chastang C; Ziol M; Chapel F; Imbert-Bismut F; Trinchet JC; Guettier C; Beaugrand M Gut; 2000 Feb; 46(2):277-82. PubMed ID: 10644325 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis. Spreux-Varoquaux O; Doll J; Dutot C; Grandjean N; Cordonnier P; Pays M; Andrieu J; Advenier C Br J Clin Pharmacol; 1991 Sep; 32(3):399-401. PubMed ID: 1777378 [TBL] [Abstract][Full Text] [Related]
40. Modeling of aceclofenac metabolism to major metabolites in healthy volunteers. Kim E; Ihm C; Kang W Drug Metab Pharmacokinet; 2016 Dec; 31(6):458-463. PubMed ID: 27839691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]